Literature DB >> 7011537

Laminin, a noncollagenous component of epithelial basement membranes synthesized by a rat yolk sac tumor.

U Wewer, R Albrechtsen, E Ruoslahti.   

Abstract

Laminin, a glycoprotein antigenically similar or identical to a component of epithelial basement membranes, was identified as a major component of the abundant extracellular matrix synthesized by an experimentally induced rat yolk sac tumor. Immunocytochemical staining revealed laminin in cultured tumor cells as well as in their extracellular matrix. The presence of soluble laminin in the culture media of the tumor cells was demonstrated using metabolic labeling followed by identification by immunoprecipitation and sodium dodecyl sulfate:polyacrylamide gel electrophoresis. This revealed two polypeptides with molecular weights of approximately 200,000 and 400,000. These comigrated with the polypeptides of mouse laminin isolated previously. The yolk sac tumor tissue grown in vivo contained laminin in the tumor cells and in the extracellular material as evidenced by immunofluorescence and immunoperoxidase staining. Immunization with the tumor matrix resulted in an antiserum that contained antilaminin and natifibronectin and was made specific for laminin by absorption with fibronectin. This antiserum precipitated laminin polypeptides from culture medium of yolk sac tumour cells and stained basement membranes in rat tissues in a manner indistinguishable from antilaminin. The presence of laminin in rat yolk sac cells, the presumed origin of our yolk sac tumor, was studied in some detail. Laminin was found to be present in normal cells of the visceral as well as the parietal yolk sac layer and in their basement membranes suggesting, but not proving, that both types of cells have ability to synthesize laminin. Production of laminin and the presence of laminin-containing basement membrane material may be important for the biological behavior of the yolk sac tumor. This tumor will also be a useful source of laminin for chemical and biological characterization of this basement membrane protein.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7011537

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Intercellular deposits of basement membrane material in active human pituitary adenomas detected by immunostaining for laminin and electron microscopy.

Authors:  S Holck; U M Wewer; R Albrechtsen
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Antagonistic effects of laminin and fibronectin in cell-to-cell and cell-to-matrix interactions in MCF-7 cultures.

Authors:  A Noel; A Callé; H Emonard; B Nusgens; J M Foidart; C M Lapiere
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

3.  Growth and characterization of normal human urothelium in vitro.

Authors:  C A Reznikoff; M D Johnson; D H Norback; G T Bryan
Journal:  In Vitro       Date:  1983-04

4.  Increased abundance of a normal cell mRNA sequence accompanies the conversion of rat mammary cuboidal epithelial cells to elongated myoepithelial-like cells in culture.

Authors:  R Barraclough; R Kimbell; P S Rudland
Journal:  Nucleic Acids Res       Date:  1984-11-12       Impact factor: 16.971

Review 5.  Extracellular matrix destruction by invasive tumor cells.

Authors:  P A Jones; Y A De Clerck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

6.  Release of tissue-type plasminogen activator is induced in rats by leukotrienes C4 and D4, but not by prostaglandins E1, E2 and I2.

Authors:  N Tranquille; J J Emeis
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

7.  Role of laminin in epithelium formation by F9 aggregates.

Authors:  A Grover; G Andrews; E D Adamson
Journal:  J Cell Biol       Date:  1983-07       Impact factor: 10.539

8.  A case report of a metastatic yolk sac carcinoma in the pulmonary artery of a young female Sprague-Dawley rat.

Authors:  Yohei Sakamoto; Takaharu Nagaoka; Kei Tamura; Hideshi Kaneko
Journal:  J Toxicol Pathol       Date:  2016-08-04       Impact factor: 1.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.